A safety panel of the European drug regulator on January 14th recommended adding the spinal condition transverse myelitis as a side effect of AstraZeneca’s Covid-19 vaccine. This is a paralysis condition caused by nerve damage that is similar to the damage found in multiple sclerosis.
If you haven’t heard of transverse myelitis, watch this video from orthopedic surgeon Dr. Joel Wallskog
https://www.youtube.com/watch?v=553qr6gme8oIn October 2021 the European Medicines Agency’s (EMA) safety committee had already recommended a similar warning be included for Johnson & Johnson’s one-shot vaccine.
Transverse myelitis was at the heart of trial halts in the early stages of development for both AstraZeneca and J&J’s shots. So it was clearly known before the vaccines were approved for general use that they could cause this condition. Dozens of clinical reports and studies prove that this problem with the vaccine was not fixed, and transverse myelitis continued to occur after the official clinical trials.
The EMA also recommended updating the product information for AstraZeneca’s vaccine regarding thrombocytopenia. See clinical reports and studies proving that this type of vaccine injury is also not rare and has been known about for some considerable time.
In view of the above facts, medical ethics requires that each individual should have been warned about these conditions at the time the jab was offered. Also shocking is the trivialisation of these conditions in the official announcements, as if they are an acceptable reaction and not at all serious. Only one third of patients with transverse myelitis have been found to fully recover from this type of paralysis.